Ange Longxiang

Chongqing Ange Longxiang was established in 2008. After eleven years of rapid development, it has become a high-tech group company integrating R&D, production, sales, export, and internet medical services. The group headquarters is located in the Erlang Overseas Students Science and Technology Entrepreneurship Park, Jiulongpo District, Chongqing, with a registered capital of 100 million yuan. The company is committed to becoming an innovative enterprise in the pharmaceutical and health industry, providing high-quality products and services for human health. It has a professional innovation team led by academicians, doctors, and senior engineers, and maintains good cooperation mechanisms with first-class domestic and foreign research institutions and expert teams.
The group is currently divided into three major sectors: commerce and trade, manufacturing, and investment.
The commerce and trade sector focuses on the agency sales of pharmaceuticals, medical devices, and in vitro diagnostic reagents. It has a high-quality pharmaceutical marketing team, most of whom hold bachelor's degrees in medicine and pharmacy. Its marketing network has covered major hospitals in Sichuan and Chongqing, and it has an office in the Chengdu area. The company focuses on academic promotion of new drugs and specialty drugs, and has multiple national general agency and regional general distribution varieties. It also has more than 40,000 square meters of modern and standardized business premises, a complete logistics distribution pipeline, and operational quality management. The company fully passed the national new GSP certification in December 2008, with annual sales of hundreds of millions of yuan.
The manufacturing sector has several wholly-owned independent subsidiaries: Chongqing Ange Longxiang Pharmaceutical Technology Co., Ltd., Chongqing Ange Longxiang Pharmaceutical Co., Ltd., Chongqing Haiteng Pharmaceutical Co., Ltd., Chongqing Bo'an Import and Export Co., Ltd., and Nanjing First Pharmaceutical Technology Co., Ltd.
Chongqing Ange Longxiang Pharmaceutical Technology Co., Ltd. is a "High-tech Enterprise", a municipal "Academician Workstation", and a municipal "Antithrombotic Drug Enterprise Engineering Technology Center". Its current R&D directions involve antitumor drugs, cardiovascular drugs, modern traditional Chinese medicine, and other fields. It is committed to the discovery of new drugs, research on new drugs (including synthesis processes, formulation processes, and product quality research), custom synthesis of drugs or intermediates, technical services, technical consulting, drug application and registration, and drug production. It owns 10 invention patents and 2 design patents, with multiple patent applications accepted and under examination. In addition, multiple self-developed projects have been approved as major scientific research projects by the Science and Technology Commission, Economic Commission, and Development and Reform Commission, and have received special fund support.
Chongqing Ange Longxiang Pharmaceutical Co., Ltd. is a manufacturer of active pharmaceutical ingredients, formulations, and pharmaceutical intermediates. It is located in the Changshou Chemical Industrial Park, covering an area of more than 60 mu, with production workshops of more than 12,000 square meters. It has continuously passed the national GMP system certification for many years, has an environmental protection treatment system meeting national standards, and has established and implemented an EHS management system.
Chongqing Haiteng Pharmaceutical Co., Ltd. and Chongqing Bo'an Import and Export Co., Ltd. mainly engage in international export and high-end customization of active pharmaceutical ingredients and intermediates. They have passed US FDA certification and high-end customer audits with zero defects multiple times consecutively, and currently have business cooperation with many well-known pharmaceutical companies in developed countries.
Nanjing First Pharmaceutical Technology Co., Ltd. focuses on the development, production, and sales of small-molecule antitumor active pharmaceutical ingredients & intermediates. Its products are positioned at the high end and are continuously upgraded with high-value-added products. It has successfully developed nearly 30 industrially producible projects to date, and most products are in the early stage of their life cycle, allowing for a relatively long period of high return.
The investment sector covers Chongqing Juyue Ange Hospital Management Co., Ltd. (an internet hospital formally approved by the Chongqing Municipal Health Commission), Shanghai Bobang Pharmaceutical Technology Co., Ltd., and other high-tech R&D enterprises, laying the foundation for the company's future diversified development plan.
Adhering to the philosophy of giving back to society and bravely assuming responsibility, the company is a welfare enterprise for people with disabilities and a practical teaching base for university students, providing multiple employment opportunities. At the same time, it actively supports public welfare undertakings: special and series activities are carried out everywhere, including assistance for the Wenchuan earthquake, Yaan earthquake, and Zhouqu mudslide donations, sponsorship of left-behind impoverished children in Youyang and Chengkou, care for children with intellectual disabilities/autism in Chongqing, voluntary blood donation, and Red Cross donations. Internally, the company has also established a caring fund to care for and protect its employees and help solve their urgent needs.

Company benefits:
I. Basic benefits
1. Social insurance (five insurances and one housing fund);
2. Employee training and development platform;
3. Year-end bonus incentives.
II. Gift money (caring)
Gift money for various red and white events (birthdays, childbirth, funerals);

III. Holiday gifts
Gifts (Dragon Boat Festival, Mid-Autumn Festival, Spring Festival)
IV. Two-day weekends, annual leave, marriage leave, maternity leave, paternity leave, and other benefits